Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments

Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Spanakis, Marios, Patelarou, Athina, Patelarou, Evridiki, Tzanakis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583457/
https://www.ncbi.nlm.nih.gov/pubmed/34770225
http://dx.doi.org/10.3390/ijerph182111711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583457/
https://www.ncbi.nlm.nih.gov/pubmed/34770225
http://dx.doi.org/10.3390/ijerph182111711

Ejemplares similares